Steris PLC Form 4 insider transactions

Mohsen Sohi, a Director of STERIS plc, sold 4,058 shares of common stock on August 10, 2026 for $235.78 per share.

Louis Shapiro, a Director of STERIS plc, received 1,025 shares of common stock on August 10, 2026.

Nirav R Shah, a Director of STERIS plc, reported multiple transactions in common stock on August 10, 2026.

Paul Edward Martin, a Director of STERIS plc, reported multiple transactions in common stock on August 10, 2026.

Christopher S Holland, a Director of STERIS plc, received 1,025 shares of common stock on August 10, 2026.

Cynthia L Feldmann, a Director of STERIS plc, reported multiple transactions in common stock on August 10, 2026.

Pierre Boulud, a Director of STERIS plc, received 1,025 shares of common stock on August 10, 2026.

Sohi Mohsen, a Director at STERIS plc, reported transactions involving ordinary shares and stock options on July 1, 2026.

John Adam Zangerle, Sr. VP, Gen Counsel, and Sec. of STERIS plc, reported a disposition of 1,419 ordinary shares on June 15, 2026.

John Adam Zangerle, Sr. VP, Gen Counsel, and Sec. of STERIS plc, reported a transaction involving the sale of 401 ordinary shares to cover tax withholding obligations.

Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, reported a transaction involving the withholding of shares for tax purposes upon vesting and provided an update on beneficial ownership.

STERIS plc reports that Sr. VP Julia Madsen disposed of 195 ordinary shares to cover tax obligations upon the vesting of restricted stock.

STERIS plc executive Kenneth E. Kohler reported a disposition of 150 ordinary shares on June 4, 2026, primarily to cover tax withholding obligations upon the vesting of restricted shares.

Mary Clare Fraser of STERIS plc reported a transaction involving the withholding of 600 ordinary shares for tax purposes upon the vesting of restricted shares.

STERIS plc President and CEO Daniel Carestio reported transactions involving the company's ordinary shares, including the vesting of restricted shares and the sale of some shares.

STERIS plc executive Karen L. Burton reported transactions involving ordinary shares, including the withholding of shares for tax purposes and details on restricted share vesting schedules.

John Adam Zangerle, Senior VP and General Counsel at STERIS plc, reported the withholding of 365 shares to cover tax obligations upon the vesting of restricted stock.

STERIS plc Vice President and Corporate Treasurer Renato Tamaro reported the withholding of 64 shares to cover tax obligations upon the vesting of restricted stock.

Senior VP Julia Madsen reported the withholding of 239 shares to cover tax obligations following the vesting of restricted stock.

STERIS SVP Kenneth E. Kohler reported the withholding of 184 shares to cover tax obligations following the vesting of restricted stock.

STERIS plc SVP and Chief HRO Mary Clare Fraser reported the withholding of 311 shares to cover tax obligations upon the vesting of restricted stock.

Senior VP and General Counsel John Adam Zangerle received equity grants and executed tax-related share withholdings.

STERIS plc V.P. & Corporate Treasurer Renato Tamaro reported the acquisition of restricted shares and stock options in a recent SEC Form 4 filing.

VP Lindsey McGowan acquired 1,155 shares and 4,036 stock options as part of a routine equity compensation plan.

Cary L. Majors, SVP and President of Healthcare at STERIS plc, reported the acquisition of restricted shares and stock options.

Senior VP Julia Madsen acquired 2,316 ordinary shares and 8,080 stock options as part of a compensation-related transaction.

STERIS plc SVP & GM Kenneth E. Kohler acquired 2,199 ordinary shares and 7,668 stock options as part of an equity compensation plan.

STERIS plc SVP & Chief HRO Mary Clare Fraser reported the acquisition of restricted shares and stock options in a Form 4 filing.

STERIS plc President and CEO Daniel A. Carestio acquired 23,736 ordinary shares and 82,740 stock options in a recent equity compensation filing.

STERIS plc CFO Karen L. Burton acquired 5,325 ordinary shares and 18,564 stock options in a routine equity compensation filing.